Literature DB >> 6791676

Coagulation abnormalities following intensive plasma exchange on the cell separator. II. Effects on factors I, II, V, VII, VIII, IX, X and antithrombin III.

A Chirnside, S J Urbaniak, C V Prowse, A J Keller.   

Abstract

The effects of intensive plasma exchange on the circulating levels of coagulation factors I, II, V, VII, VIII, IX, X and antithrombin III were determined. During courses of daily exchange marked cumulative reductions of coagulation factors may occur, particularly in the case of factors I, II and X, although usually remaining above the levels considered adequate for haemostasis. The extent of cumulative reduction and subsequent recovery differed for patients with different diseases. While antithrombin III levels were reduced during plasma exchange the results suggest that this may be partly due to consumption as well as physical removal. The very low incidence of haemorrhagic sequelae and absence of thrombotic events following plasma exchange at this Centre is explained by the maintenance of adequate levels of coagulation factors and of antithrombin III even during courses of daily plasma exchange.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6791676     DOI: 10.1111/j.1365-2141.1981.00627.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

Review 1.  Plasmapheresis: technique and complications.

Authors:  P M Reimann; P D Mason
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

2.  Recurring extracorporeal circuit clotting during continuous renal replacement therapy resolved after single-session therapeutic plasma exchange.

Authors:  Tibor Fülöp; Adrian Cosmin; Luis A Juncos
Journal:  J Clin Apher       Date:  2011-05-26       Impact factor: 2.821

3.  Studies on the procurement of blood coagulation factor VIII: effects of plasma freezing rate and storage conditions on cryoprecipitate quality.

Authors:  A Farrugia; C Prowse
Journal:  J Clin Pathol       Date:  1985-04       Impact factor: 3.411

4.  The Role of Leukapheresis in the Current Management of Hyperleukocytosis in Newly Diagnosed Childhood Acute Lymphoblastic Leukemia.

Authors:  Rosa Nguyen; Sima Jeha; Yinmei Zhou; Xueyuan Cao; Cheng Cheng; Deepa Bhojwani; Patrick Campbell; Scott C Howard; Jeffrey Rubnitz; Raul C Ribeiro; John T Sandlund; Tanja Gruber; Hiroto Inaba; Ching-Hon Pui; Monika L Metzger
Journal:  Pediatr Blood Cancer       Date:  2016-05-17       Impact factor: 3.167

Review 5.  Early clinical complications after ABO-incompatible live-donor kidney transplantation: a national study of Medicare-insured recipients.

Authors:  Krista L Lentine; David Axelrod; Christina Klein; Christopher Simpkins; Huiling Xiao; Mark A Schnitzler; Janet E Tuttle-Newhall; Vikas R Dharnidharka; Daniel C Brennan; Dorry L Segev
Journal:  Transplantation       Date:  2014-07-15       Impact factor: 4.939

6.  Therapeutic plasma exchange for pediatric nonrenal disease indications and outcomes: A single-center experience.

Authors:  Saravanan Margabandhu; Suchitra Ranjit; Indira Jayakumar; Chitra Sundaramoorthy; Mahesh Janarthanan; Jayakumar Reddy; Meena Thiagarajan; Shyamala Jayamoorthy; Latha Vishwanathan
Journal:  Asian J Transfus Sci       Date:  2018 Jul-Dec

Review 7.  Role of therapeutic apheresis and phlebotomy techniques in anaesthesia and critical care.

Authors:  Neeta Bose; Hitendra Kanzariya
Journal:  Indian J Anaesth       Date:  2014-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.